ArticleBlood2022

Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia.

Saara Laukkanen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.